相关实验视频
Updated: Jun 15, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
在帕金森病精神病中药物治疗的患者和医生的观点:混合方法探索性研究
Olaf Rose1,2, Tobias Hinteregger1, Eugen Trinka3,4,5
1Institute of Pharmacy, Pharmaceutical Biology and Clinical Pharmacy, Paracelsus Medical University, Strubergasse 21, 5020 Salzburg, Austria.
Pharmacy (Basel, Switzerland)
|January 21, 2026
概括
患有帕金森病精神病 (PDP) 的患者在治疗疗效和副作用方面与医生有不同的优先级. 改善克洛沙平的监测和患者报告的结果可以提高护理.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
背景情况:
- 帕金森病精神病 (PDP) 是一种常见且令人衰弱的非运动症状.
- 克洛扎平和奎平是PDP的主要治疗方法,但患者和医生的观点可能有所不同.
研究的目的:
- 为了比较患者的经验与医生对帕金森病精神病的处方实践.
- 从患者和医生的角度探索感知到的疗效,不良影响和日常功能.
主要方法:
- 一项探索性研究,涉及与PDP患者进行半结构化采访,并为医生提供结构化问卷.
- 专题分析和数据三角化被用来比较患者报告的结果和医生处方模式.
主要成果:
- 大多数接受提氨酸治疗的患者报告持续的幻觉,镇静和自主能力下降.
- 由于担心克洛扎的农细胞形成风险和监测复杂性,医生倾向于使用奎蒂亚平.
- 患者的优先事项集中在症状控制和独立,与医生强调安全性和可行性形成鲜明对比.
结论:
- 在管理PDP时,患者的优先事项 (症状控制,独立性) 和医生的决定 (安全性,可行性) 之间存在差距.
- 促进克洛沙平的监测和整合患者报告的结果对于以患者为中心的PDP管理至关重要.
相关概念视频
Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications

